Sensitivity of dendritic cells to NK-mediated lysis depends on the inflammatory environment and is modulated by CD54/CD226-driven interactions

Journal of Leukocyte Biology

Volumn 100, Issue 4, 2016, Pages 781-789

  Smith, Laura E ^a   Olszewski, Marcin A ^a   Georgoudaki, Anna Maria ^b   Wagner, Arnika K ^b   Hägglöf, Thomas ^b   Karlsson, Mikael C I ^b   Dominguez Villar, Margarita ^c,d   Garcia Cozar, Francisco ^d   Mueller, Steffan ^e   Ravens, Inga ^f   Bernhardt, Günter ^f   Chambers, Benedict J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Stony Brook ^*  (United States)

^f HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cytokine; Cytotoxicity; Immune modulation

Indexed keywords

B7 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; PROGRAMMED DEATH 1 LIGAND 1; CD226 ANTIGEN; FLT3 LIGAND PROTEIN; MEMBRANE PROTEIN; PDCD1 PROTEIN, MOUSE; POLIOVIRUS RECEPTOR; PROGRAMMED DEATH 1 RECEPTOR; RECOMBINANT PROTEIN; T LYMPHOCYTE ANTIGEN; VIRUS RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; IMMUNE SYSTEM; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYSIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; CELL CULTURE; CYTOTOXICITY; DEFICIENCY; GENE; GRAFT REJECTION; IMMUNOLOGY; KNOCKOUT MOUSE; SPLEEN; TRANSPLANTATION;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; GENES, RAG-1; GRAFT REJECTION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-18; KILLER CELLS, NATURAL; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; SPLEEN;

EID: 84990066633     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3A0615-271RR     Document Type: Article

References (61)

1. Ziegler-Heitbrock, L., Ancuta, P., Crowe, S., Dalod, M., Grau, V., Hart, D. N., Leenen, P. J., Liu, Y. J., MacPherson, G., Randolph, G. J., Scherberich, J., Schmitz, J., Shortman, K., Sozzani, S., Strobl, H., Zembala, M., Austyn, J. M., Lutz, M. B. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116, e74-e80.
2. Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H. W., Park, C. G., Steinman, R. M., Nussenzweig, M. C. (2007) Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107-111.
3. Shortman, K., Liu, Y. J. (2002) Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151-161.
4. Degli-Esposti, M. A., Smyth, M. J. (2005) Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 5, 112-124.
5. Buentke, E., Heffler, L. C., Wilson, J. L., Wallin, R. P., Löfman, C., Chambers, B. J., Ljunggren, H. G., Scheynius, A. (2002) Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Malasseziainfluenced cell interaction. J. Invest. Dermatol. 119, 850-857.
6. Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., Sallusto, F. (2004) Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5, 1260-1265.
7. Persson, C. M., Chambers, B. J. (2010) Plasmacytoid dendritic cellinduced migration and activation of NK cells in vivo. Eur. J. Immunol. 40, 2155-2164.
8. Korsgren, M., Persson, C. G., Sundler, F., Bjerke, T., Hansson, T., Chambers, B. J., Hong, S., Van Kaer, L., Ljunggren, H. G., Korsgren, O. (1999) Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J. Exp. Med. 189, 553-562.
9. Yuan, D., Wilder, J., Dang, T., Bennett, M., Kumar, V. (1992) Activation of B lymphocytes by NK cells. Int. Immunol. 4, 1373-1380.
10. Shah, P. D., Gilbertson, S. M., Rowley, D. A. (1985) Dendritic cells that have interacted with antigen are targets for natural killer cells. J. Exp. Med. 162, 625-636.
11. Chambers, B. J., Salcedo, M., Ljunggren, H. G. (1996) Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5, 311-317.
12. Carbone, E., Terrazzano, G., Ruggiero, G., Zanzi, D., Ottaiano, A., Manzo, C., Kärre, K., Zappacosta, S. (1999) Recognition of autologous dendritic cells by human NK cells. Eur. J. Immunol. 29, 4022-4029.
13. Wilson, J. L., Heffler, L. C., Charo, J., Scheynius, A., Bejarano, M. T., Ljunggren, H. G. (1999) Targeting of human dendritic cells by autologous NK cells. J. Immunol. 163, 6365-6370.
14. Parajuli, P., Nishioka, Y., Nishimura, N., Singh, S. M., Hanibuchi, M., Nokihara, H., Yanagawa, H., Sone, S. (1999) Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing. J. Leukoc. Biol. 65, 764-770.
15. Hayakawa, Y., Screpanti, V., Yagita, H., Grandien, A., Ljunggren, H. G., Smyth, M. J., Chambers, B. J. (2004) NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J. Immunol. 172, 123-129.
16. Persson, C. M., Assarsson, E., Vahlne, G., Brodin, P., Chambers, B. J. (2008) Critical role of Qa1b in the protection of mature dendritic cells from NK cell-mediated killing. Scand. J. Immunol. 67, 30-36.
17. Della Chiesa, M., Vitale, M., Carlomagno, S., Ferlazzo, G., Moretta, L., Moretta, A. (2003) The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur. J. Immunol. 33, 1657-1666.
18. Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., Papaioannou, V. E. (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869-877.
19. Borriello, F., Sethna, M. P., Boyd, S. D., Schweitzer, A. N., Tivol, E. A., Jacoby, D., Strom, T. B., Simpson, E. M., Freeman, G. J., Sharpe, A. H. (1997) B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6, 303-313.
20. Mueller, S., Rosenquist, T. A., Takai, Y., Bronson, R. A., Wimmer, E. (2003) Loss of nectin-2 at Sertoli-spermatid junctions leads to male infertility and correlates with severe spermatozoan head and midpiece malformation, impaired binding to the zona pellucida, and oocyte penetration. Biol. Reprod. 69, 1330-1340.
21. Maier, M. K., Seth, S., Czeloth, N., Qiu, Q., Ravens, I., Kremmer, E., Ebel, M., Müller, W., Pabst, O., Förster, R., Bernhardt, G. (2007) The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens. Eur. J. Immunol. 37, 2214-2225.
22. Koller, B. H., Marrack, P., Kappler, J. W., Smithies, O. (1990) Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science 248, 1227-1230.
23. Nishimura, H., Minato, N., Nakano, T., Honjo, T. (1998) Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 10, 1563-1572.
24. Gilliet, M., Boonstra, A., Paturel, C., Antonenko, S., Xu, X. L., Trinchieri, G., O’Garra, A., Liu, Y. J. (2002) The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195, 953-958.
25. Naik, S. H., Proietto, A. I., Wilson, N. S., Dakic, A., Schnorrer, P., Fuchsberger, M., Lahoud, M. H., O’Keeffe, M., Shao, Q. X., Chen, W. F., Villadangos, J. A., Shortman, K., Wu, L. (2005) Cutting edge: generation of splenic CD8+ and CD82 dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174, 6592-6597.
26. Norbury, C. C., Chambers, B. J., Prescott, A. R., Ljunggren, H. G., Watts, C. (1997) Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27, 280-288.
27. Seth, S., Georgoudaki, A. M., Chambers, B. J., Qiu, Q., Kremmer, E., Maier, M. K., Czeloth, N., Ravens, I., Foerster, R., Bernhardt, G. (2009) Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells. J. Leukoc. Biol. 86, 91-101.
28. Oberg, L., Johansson, S., Michaëlsson, J., Tomasello, E., Vivier, E., Kärre, K., Höglund, P. (2004) Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo-role of KARAP/DAP12-dependent and-independent pathways. Eur. J. Immunol. 34, 1646-1653.
29. Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., Caligiuri, M. A. (2001) Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97, 3146-3151.
30. Giroux, M., Yurchenko, E., St-Pierre, J., Piccirillo, C. A., Perreault, C. (2007) T Regulatory cells control numbers of NK cells and CD8alpha+ immature dendritic cells in the lymph node paracortex. J. Immunol. 179, 4492-4502.
31. Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D. M., Okumura, K., Azuma, M., Yagita, H. (2002) Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169, 5538-5545.
32. Gaudreau, S., Guindi, C., Ménard, M., Benabdallah, A., Dupuis, G., Amrani, A. (2010) GM-CSF induces bone marrow precursors of NOD mice to skew into tolerogenic dendritic cells that protect against diabetes. Cell. Immunol. 265, 31-36.
33. Alvarez, I. B., Pasquinelli, V., Jurado, J. O., Abbate, E., Musella, R. M., de la Barrera, S. S., García, V. E. (2010) Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. J. Infect. Dis. 202, 524-532.
34. Benson, Jr., D. M., Bakan, C. E., Mishra, A., Hofmeister, C. C., Efebera, Y., Becknell, B., Baiocchi, R. A., Zhang, J., Yu, J., Smith, M. K., Greenfield, C. N., Porcu, P., Devine, S. M., Rotem-Yehudar, R., Lozanski, G., Byrd, J. C., Caligiuri, M. A. (2010) The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. Blood 116, 2286-2294.
35. Terme, M., Ullrich, E., Aymeric, L., Meinhardt, K., Desbois, M., Delahaye, N., Viaud, S., Ryffel, B., Yagita, H., Kaplanski, G., Prévost-Blondel, A., Kato, M., Schultze, J. L., Tartour, E., Kroemer, G., Chaput, N., Zitvogel, L. (2011) IL-18 induces PD-1-dependent immunosuppression in cancer. Cancer Res. 71, 5393-5399.
36. Golden-Mason, L., Klarquist, J., Wahed, A. S., Rosen, H. R. (2008) Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences. J. Immunol. 180, 3637-3641.
37. Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., Freeman, G. J. (2007) Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27, 111-122.
38. Carbone, E., Ruggiero, G., Terrazzano, G., Palomba, C., Manzo, C., Fontana, S., Spits, H., Kärre, K., Zappacosta, S. (1997) A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J. Exp. Med. 185, 2053-2060.
39. Martín-Fontecha, A., Assarsson, E., Carbone, E., Kärre, K., Ljunggren, H. G. (1999) Triggering of murine NK cells by CD40 and CD86 (B7-2). J. Immunol. 162, 5910-5916.
40. Chong, A. S., Boussy, I. A., Jiang, X. L., Lamas, M., Graf, Jr., L. H. (1994) CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity. Cell. Immunol. 157, 92-105.
41. Topham, N. J., Hewitt, E. W. (2009) Natural killer cell cytotoxicity: how do they pull the trigger? Immunology 128, 7-15.
42. Georgiev, H., Danisch, S., Chambers, B. J., Shibuya, A., Forster, R., Bernhardt, G. (2014) To the editor: TIGIT versus CD226: hegemony or coexistence? Eur. J. Immunol. 44, 307-308.
43. Chambers, B. J., Ljunggren, H. G. (1999) NK cells. In Dendritic Cells (M. T. Lotze, A. W. Thomson, eds.), Academic Press, San Diego, 257-268.
44. Serbina, N. V., Salazar-Mather, T. P., Biron, C. A., Kuziel, W. A., Pamer, E. G. (2003) TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19, 59-70.
45. Naik, S. H., Metcalf, D., van Nieuwenhuijze, A., Wicks, I., Wu, L., O’Keeffe, M., Shortman, K. (2006) Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 7, 663-671.
46. Barber, D. F., Faure, M., Long, E. O. (2004) LFA-1 contributes an early signal for NK cell cytotoxicity. J. Immunol. 173, 3653-3659.
47. Shirakawa, J., Wang, Y., Tahara-Hanaoka, S., Honda, S., Shibuya, K., Shibuya, A. (2006) LFA-1-dependent lipid raft recruitment of DNAM-1 (CD226) in CD4+ T cell. Int. Immunol. 18, 951-957.
48. Shirakawa, J., Shibuya, K., Shibuya, A. (2005) Requirement of the serine at residue 329 for lipid raft recruitment of DNAM-1 (CD226). Int. Immunol. 17, 217-223.
49. Shibuya, K., Shirakawa, J., Kameyama, T., Honda, S., Tahara-Hanaoka, S., Miyamoto, A., Onodera, M., Sumida, T., Nakauchi, H., Miyoshi, H., Shibuya, A. (2003) CD226 (DNAM-1) is involved in lymphocyte functionassociated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J. Exp. Med. 198, 1829-1839.
50. Zhang, Z., Wu, N., Lu, Y., Davidson, D., Colonna, M., Veillette, A. (2015) DNAM-1 controls NK cell activation via an ITT-like motif. J. Exp. Med. 212, 2165-2182.
51. Martinet, L., Ferrari De Andrade, L., Guillerey, C., Lee, J. S., Liu, J., Souza-Fonseca-Guimaraes, F., Hutchinson, D. S., Kolesnik, T. B., Nicholson, S. E., Huntington, N. D., Smyth, M. J. (2015) DNAM-1 expression marks an alternative program of NK cell maturation. Cell Reports 11, 85-97.
52. Pende, D., Bottino, C., Castriconi, R., Cantoni, C., Marcenaro, S., Rivera, P., Spaggiari, G. M., Dondero, A., Carnemolla, B., Reymond, N., Mingari, M. C., Lopez, M., Moretta, L., Moretta, A. (2005) PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. Mol. Immunol. 42, 463-469.
53. Magri, G., Muntasell, A., Romo, N., Sáez-Borderías, A., Pende, D., Geraghty, D. E., Hengel, H., Angulo, A., Moretta, A., López-Botet, M. (2011) NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117, 848-856.
54. Martinet, L., Smyth, M. J. (2015) Balancing natural killer cell activation through paired receptors. Nat. Rev. Immunol. 15, 243-254.
55. Chan, C. J., Martinet, L., Gilfillan, S., Souza-Fonseca-Guimaraes, F., Chow, M. T., Town, L., Ritchie, D. S., Colonna, M., Andrews, D. M., Smyth, M. J. (2014) The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat. Immunol. 15, 431-438.
56. Stanietsky, N., Mandelboim, O. (2010) Paired NK cell receptors controlling NK cytotoxicity. FEBS Lett. 584, 4895-4900.
57. Stanietsky, N., Rovis, T. L., Glasner, A., Seidel, E., Tsukerman, P., Yamin, R., Enk, J., Jonjic, S., Mandelboim, O. (2013) Mouse TIGIT inhibits NKcell cytotoxicity upon interaction with PVR. Eur. J. Immunol. 43, 2138-2150.
58. Levin, S. D., Taft, D. W., Brandt, C. S., Bucher, C., Howard, E. D., Chadwick, E. M., Johnston, J., Hammond, A., Bontadelli, K., Ardourel, D., Hebb, L., Wolf, A., Bukowski, T. R., Rixon, M. W., Kuijper, J. L., Ostrander, C. D., West, J. W., Bilsborough, J., Fox, B., Gao, Z., Xu, W., Ramsdell, F., Blazar, B. R., Lewis, K. E. (2011) Vstm3 is a member of the CD28 family and an important modulator of T-cell function. Eur. J. Immunol. 41, 902-915.
59. Joller, N., Hafler, J. P., Brynedal, B., Kassam, N., Spoerl, S., Levin, S. D., Sharpe, A. H., Kuchroo, V. K. (2011) Cutting edge: TIGIT has T cellintrinsic inhibitory functions. J. Immunol. 186, 1338-1342.
60. Topalian, S. L., Drake, C. G., Pardoll, D. M. (2012) Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity. Curr. Opin. Immunol. 24, 207-212.
61. Morandi, B., Mortara, L., Chiossone, L., Accolla, R. S., Mingari, M. C., Moretta, L., Moretta, A., Ferlazzo, G. (2012) Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. PLoS One 7, e39170.